Novo Nordisk estimates that 813 million people have obesity, but its drugs have reached only 1.1 million
Mounjaro vs Zepbound: Understanding the Difference The difference between mounjaro vs zepbound is significant, especially regarding treatment goals and insurance coverage
While neither semaglutide nor tirzepatide is superior, one may work better for you
Cognitive Decline and Neurodegenerative Conditions Cognitive decline and neurodegenerative conditions show substantial preclinical evidence across multiple pathologies: Stroke models: BPC-157 given during reperfusion counteracted neuronal damage and produced full functional recovery in spatial memory, motor coordination, and balance tests Parkinsons models: MPTP-induced models showed reduced motor symptoms (tremor, rigidity, akinesia), protection of nigrostriatal dopaminergic neurons, and near-complete prevention of mortality Multiple sclerosis models: Cuprizone-induced demyelination resulted in significantly less brain damage and reduced clinical abnormalities when BPC-157 was given in drinking water or intragastrically Traumatic brain injury: Falling weight model studies demonstrated reduced hemorrhage, decreased brain lacerations and edema, and improved early outcomes These diverse models share common mechanisms
Molecular glues are already approved for multiple myeloma and myelodysplastic syndromes and are under investigation for additional malignancies
